MDC medlab clinical limited
Add to My Watchlist 0.00% ! $6.60

90% decrease in company value since commencement of phase2...

  1. silvahman
    4,445 Posts.
    lightbulb Created with Sketch. 337
    clock Created with Sketch.
    19/10/20
    10:27
    Post #: 48192743
    90% decrease in company value since commencement of phase2 nanabis. It was successful after 2 years and resulted in 50% decrease in sp. I think large vote against it was due to this. Perhaps heading into phase3 will have opposite effect as other biotech with unsuccessful trial and no income worth over 100mill$.

    why issue cheap options when sp performance is worse off after successful phase2 doesnt add up. Hence the large vote against imo.

    interesting 24 months ahead
    MDC Price at posting: 22.0¢ Sentiment: Hold Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
NEWS World’s largest pollucite-hosted caesium pegmatite resource defined
right-arrow Created with Sketch.
NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
NEWS Cangallo drilling returns wide copper intercepts
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.